NCT06631196

Brief Summary

The goal of this clinical trial is to determine the effect of Jacobson's progressive muscle relaxation technique on anxiety and fatigue among children with leukemia undergoing chemotherapy. The main research hypotheses are;

  • Children with leukemia who receive Jacobson's progressive muscle relaxation technique exhibit less anxiety than those who don't receive it.
  • Children with leukemia who receive Jacobson's progressive muscle relaxation technique exhibit less fatigue than those who don't receive it. Researchers will compare Jacobson's progressive muscle relaxation technique with standardized nursing care on a child's anxiety and fatigue.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable leukemia

Timeline
Completed

Started Nov 2024

Shorter than P25 for not_applicable leukemia

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 7, 2024

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 8, 2024

Completed
24 days until next milestone

Study Start

First participant enrolled

November 1, 2024

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2025

Completed
Last Updated

October 8, 2024

Status Verified

October 1, 2024

Enrollment Period

1.1 years

First QC Date

October 7, 2024

Last Update Submit

October 7, 2024

Conditions

Keywords

Jacobson's Progressive Muscle Relaxation TechniqueAnxietyFatigueChildrenLeukemiaChemotherapynursing care

Outcome Measures

Primary Outcomes (1)

  • Pediatric Quality of Life Inventory (PedsQL) Multidimensional Fatigue Scale:

    This tool was developed initially by (Smets et al., 1995) to assess fatigue for the subject. The scale comprised 18 items and 3 subscales which are; General Fatigue, Sleep/Rest Fatigue, and Cognitive Fatigue. The format, instructions, Likert response scale, and scoring method are identical to the PedsQL 4.0 Generic Core Scales, with higher scores indicating a better health-related quality of life (lower fatigue symptoms). A five-point Likert scale was used to evaluate the responses in which (zero= never a problem; one = almost never a problem; two= sometimes a problem; three= often a problem; four= almost always a problem). Items are reverse-scored and linearly transformed to a 0-100 scale as follows: * 0 = 100-76 * 1 = 75-51 * 2 = 50-26 * 3 = 25-1 * 4= 0

    before and after intervention.

Secondary Outcomes (1)

  • Spence Children's Anxiety Scale - Child (SCAS-Child)

    before and after intervention.

Other Outcomes (1)

  • Socio Demographic and Medical Data of Children with leukemia Undergoing Chemotherapy Structured Interview Schedule

    before intervention

Study Arms (2)

control group

NO INTERVENTION

children will be subjected to standardized nursing care.

Interventional group (Jacobson's PMRT)

EXPERIMENTAL

children will be subjected to the implementation of Jacobson's progressive muscle relaxation technique for children with leukemia undergoing chemotherapy.

Procedure: Jacobson's PMRT

Interventions

each child in the intervention group will perform five sessions of Jacobson's PMRT. Each session lasted for 15-20 minutes under the supervision of the researcher.

Interventional group (Jacobson's PMRT)

Eligibility Criteria

Age7 Years - 15 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Children diagnosed with leukemia and received chemotherapy sessions.
  • Age ranged from 7 to 15 years.

You may not qualify if:

  • other disorders such as neurological diseases, cerebrovascular accidents, or mental illness.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (7)

  • Sulistyawati, E., Allenidekania, A., & Gayatri, D. (2021). Effect of progressive muscle relaxation on sleep quality and side effects of chemotherapy in children with cancer: randomized clinical trial. Open Access Macedonian Journal of Medical Sciences, 9(T4), 300-308. https://doi.org/10.3889/oamjms.2021.5774

    RESULT
  • Pouraboli B, Poodineh Z, Jahani Y. The Effect of Relaxation Techniques on Anxiety, Fatigue and Sleep Quality of Parents of Children with Leukemia under Chemotherapy in South East Iran. Asian Pac J Cancer Prev. 2019 Oct 1;20(10):2903-2908. doi: 10.31557/APJCP.2019.20.10.2903.

  • Mohammed Ahmed Mohammed, E., Ali Ibrahim Almanzlawi, H., & Attia Abdel Naby Raslan, H. (2020). Effect of Progressive Muscle Relaxation on Pain and Fatigue among Post Cardiac Surgery Patients. Egyptian Journal of Health Care, 11(2), 736-745. https://doi:10.21608/ejhc.2020.180367

    RESULT
  • Haggag, W, E., Soliman, H. (1997). The Arabic version of multidimensional fatigue inventory: reliability, validity and findings in three groups. Egyptian Journal of Psychiatry, 20(1), 85-97.

    RESULT
  • Giri A, Tanaya K. (2019). Effect of Jacobson's progressive muscle relaxation exercise on anxiety among children diagnosed with leukemia admitted in selected hospital of Cuttack. International Journal of Health Sciences & Research, 9(2),151-155.

    RESULT
  • Baccouche, K., Walha, A., Medhaffar, M., Kammoun, W., Ayadi, H., Moalla, Y., … Ghribi, F. (2017). Evaluation of Anxiety in Children with Acute Leukemia: A Prospective Study of 20 Cases. European Psychiatry, 41(S1), s131-s131. doi:10.1016/j.eurpsy.2017.01.1947

    RESULT
  • Ali, N.S.( 2021). The Arabic version of Spence Children's Anxiety Scale - Child (SCAS-Child). Available from: https://www.scaswebsite.com/wp-content/uploads/2021/07/scas-child-arabic.pdf

    RESULT

MeSH Terms

Conditions

LeukemiaAnxiety DisordersFatigue

Condition Hierarchy (Ancestors)

Neoplasms by Histologic TypeNeoplasmsHematologic DiseasesHemic and Lymphatic DiseasesMental DisordersSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Eman Badr, Phds

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 7, 2024

First Posted

October 8, 2024

Study Start

November 1, 2024

Primary Completion

November 30, 2025

Study Completion

November 30, 2025

Last Updated

October 8, 2024

Record last verified: 2024-10